Jennyfer Poveda
Physician Assistant · West Palm Beach, FLNPI 1720676539
Payments from drug & device makers
Across 372 payments — averaging $21.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$877
- Lilly USA, LLC$625
- Novo Nordisk$542
- Bayer$534
- Boehringer Ingelheim$469
- plus $4K from 34 others
What the payments were for
- Food & beverage$8,120100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 37 | $1,128 |
| AbbVie | 40 | $877 |
| Lilly USA, LLC | 37 | $625 |
| Novo Nordisk | 29 | $542 |
| Bayer | 23 | $534 |
| Boehringer Ingelheim | 24 | $469 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $432 |
| Pfizer | 25 | $431 |
| Sanofi-aventis U.S. LLC | 19 | $352 |
| Amgen | 12 | $322 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $288 |
| Biohaven Pharmaceutical Holding Company Ltd. | 11 | $239 |
| Corcept Therapeutics | 5 | $210 |
| Merck | 11 | $200 |
| Exact Sciences | 8 | $172 |
| Phathom Pharmaceuticals, Inc. | 1 | $139 |
| Lexicon Pharmaceuticals, Inc. | 1 | $125 |
| GSK | 8 | $121 |
| Abbott | 5 | $108 |
| Vertos Medical, Inc. | 1 | $98 |
| Xeris Pharmaceuticals, Inc. | 3 | $72 |
| Novartis | 4 | $68 |
| Esperion Therapeutics, Inc. | 1 | $68 |
| Johnson & Johnson | 4 | $67 |
| Edwards Lifesciences | 3 | $57 |
| Dexcom, Inc. | 3 | $56 |
| Biohaven Pharmaceuticals, Inc. | 2 | $40 |
| Idorsia Pharmaceuticals US Inc | 2 | $38 |
| Vifor Pharma, Inc. | 1 | $32 |
| Sanofi Pasteur Inc. | 2 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Corium, LLC | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Grifols USA, LLC | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Saluda Medical Americas, Inc. | 1 | $15 |
| Lifescan, Inc. | 1 | $14 |
| Nevro Corp. | 1 | $13 |
| GRT US Holding, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,120 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 105 | $117,003 |
| OzempicSemaglutide | 76 | $94,876 |
| TrulicityDulaglutide | 81 | $93,947 |
| JanuviaSitagliptin Phosphate | 24 | $35,125 |
| EliquisApixaban | 31 | $32,975 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 24 | $31,929 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $27,235 |
| LinzessLinaclotide | 22 | $20,871 |
| KerendiaFinerenone | 16 | $19,508 |
| VraylarCariprazine Hcl | 11 | $17,813 |
| FarxigaDapagliflozin Propanediol | 11 | $15,665 |
| SymbicortBudesonide/Formoterol Fumarate | 41 | $11,167 |
| Repatha SureclickEvolocumab | 11 | $6,201 |
| Diclofenac Sodium | 96 | $3,418 |
| Atorvastatin Calcium | 309 | $2,549 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $469 | $117,003105 claims |
| Novo NordiskOzempic | $542 | $94,87676 claims |
| Lilly USA, LLCTrulicity | $625 | $93,94781 claims |
| AbbVieLinzess, Vraylar, Synthroid | $877 | $40,55254 claims |
| MerckJanuvia | $200 | $35,12524 claims |
| PfizerEliquis | $431 | $32,97531 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $352 | $31,92924 claims |
| GSKTrelegy Ellipta | $121 | $27,23526 claims |
| AstraZenecaFarxiga, Symbicort | $1,128 | $26,83252 claims |
| BayerKerendia | $534 | $19,50816 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in West Palm Beach
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.